4-(4-(4-chlorobenzoyl)-3-(4-chlorophenyl)piperazine-1-carbonyl)isoquinolin-1(2H)-one

ID: ALA4177474

Chembl Id: CHEMBL4177474

PubChem CID: 145978645

Max Phase: Preclinical

Molecular Formula: C27H21Cl2N3O3

Molecular Weight: 506.39

Molecule Type: Small molecule

Names and Identifiers

Canonical SMILES:  O=C(c1c[nH]c(=O)c2ccccc12)N1CCN(C(=O)c2ccc(Cl)cc2)C(c2ccc(Cl)cc2)C1

Standard InChI:  InChI=1S/C27H21Cl2N3O3/c28-19-9-5-17(6-10-19)24-16-31(13-14-32(24)26(34)18-7-11-20(29)12-8-18)27(35)23-15-30-25(33)22-4-2-1-3-21(22)23/h1-12,15,24H,13-14,16H2,(H,30,33)

Standard InChI Key:  RGJCSLWUGZDVNY-UHFFFAOYSA-N

Alternative Forms

1. Parent:

   

   ALA4177474

   ---

Molecule Features

Natural Product: No

Oral: No

Chemical Probe: No

Parenteral: No

Molecule Type: Small molecule

Topical: No

First In Class: No

Black Box: No

Chirality: No

Availability: No

Prodrug: No

Calculated Properties

Molecular Weight: 506.39

Molecular Weight (Monoisotopic): 505.0960

AlogP: 5.17

#Rotatable Bonds: 3

Polar Surface Area: 73.48

Molecular Species: NEUTRAL

HBA: 3

HBD: 1

#RO5 Violations: 2

HBA (Lipinski): 6

HBD (Lipinski): 1

#RO5 Violations (Lipinski): 2

CX Acidic pKa: 11.58

CX Basic pKa: ┄

CX LogP: 4.38

CX LogD: 4.38

Aromatic Rings: 4

Heavy Atoms: 35

QED Weighted: 0.42

Np Likeness Score: -1.20

References

1. Mizojiri R, Nakata D, Satoh Y, Morishita D, Shibata S, Iwatani-Yoshihara M, Kosugi Y, Kosaka M, Takeda J, Sasaki S, Takami K, Fukuda K, Kamaura M, Sasaki S, Arai R, Cary DR, Imaeda Y..  (2017)  Discovery of Novel 5-(Piperazine-1-carbonyl)pyridin-2(1H)-one Derivatives as Orally eIF4A3-Selective Inhibitors.,  8  (10): [PMID:29057054] [10.1021/acsmedchemlett.7b00283]

Source

Source(1):

• Scientific Literature